( University of Pennsylvania School of Medicine ) An HIV drug that redirects immune cell traffic significantly reduces the incidence of a dangerous complication that often follows bone marrow transplants for blood cancer patients, according to research from the University of Pennsylvania that will be published today in the New England Journal of Medicine. The findings represent a new tactic for ...
